Aceper

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aceper

Understanding Aceper

Aceper is a pharmacological agent classified as an antipsychotic. It is primarily used in the management and treatment of certain mental health or mood conditions, such as schizophrenia and bipolar disorder. The medication belongs to a class of drugs known as atypical antipsychotics, which are designed to influence specific chemical messengers in the brain.

Mechanism of Action

Aceper works by modulating the activity of neurotransmitters, specifically dopamine and serotonin. These chemicals are essential for transmitting signals between nerve cells and play a significant role in regulating mood, perception, and behavior. By balancing these substances, the medication helps to reduce symptoms associated with psychological imbalances.

Therapeutic Purpose

The primary goal of Aceper therapy is to stabilize brain chemistry to improve clear thinking, reduce nervous tension, and help individuals participate more effectively in daily life. In the context of schizophrenia, it is utilized to address symptoms like hallucinations or disorganized thinking. For individuals with bipolar disorder, it may be used to manage episodes of mania or as a long-term mood stabilizer.

Clinical Applications

Beyond its core uses, Aceper may be prescribed for other conditions as determined by a healthcare provider. Its development focused on providing a therapeutic option that addresses both positive symptoms (such as agitation) and negative symptoms (such as social withdrawal) associated with complex psychiatric disorders.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. MedlinePlus Drug Information on Perindopril

What side effects are possible with Aceper?

Possible Side Effects and Safety Information

Official regulatory documents classify the potential side effects of Aceper (Perindopril) based on their documented frequency in clinical trials and post-marketing surveillance. This classification helps define the medicine's formal safety profile, focusing exclusively on adverse reactions and documented safety constraints.


Frequency-Classified Adverse Reactions

The most frequent adverse event listed in the official safety profile is a Cough (non-productive and persistent), classified as Very Common (ge 10%). Reactions classified as Common (1% to <10%) include Headache, Dizziness, Asthenia (weakness), Hypotension (low blood pressure), and gastrointestinal disturbances such as Nausea and Diarrhea. Less frequent reactions are grouped into Uncommon (0.1% to <1%), Rare (0.01% to <0.1%), and Very Rare (<0.01%) categories, which include events like Angioedema.


Serious Adverse Reactions and Safety Constraints

Several serious adverse reactions are explicitly documented in regulatory labeling. The most critical, though uncommon, concern is Angioedema, involving potentially life-threatening swelling of the face, tongue, or larynx. Other serious reactions include Acute Renal Failure and Hepatic Failure. Symptomatic Hypotension is noted as being more likely to occur following the initial dose or when the dose is increased.

Safety constraints define when the medicine should not be used. Aceper is contraindicated in patients with a prior history of angioedema related to ACE inhibitor use. It is also formally contraindicated during the second and third trimesters of pregnancy due to the risk of fetal morbidity. Use in patients with severe renal impairment is not recommended according to official labels.

Overdose and Emergency Response

Overdose and when to seek help

Aceper (acetaminophen/paracetamol) overdose is a medical emergency that carries a significant risk of severe, potentially fatal liver damage (hepatic necrosis). Prompt medical attention is critical for adults and children following any suspected accidental overdose, even if no immediate signs or symptoms are present.

Symptoms of overdose may be non-specific and delayed. Initial manifestations often include anorexia, nausea, vomiting, malaise, or diaphoresis (sweating). Since the toxic effects may not become apparent for 24 to 72 hours, the absence of initial symptoms must not delay seeking care. Delayed symptoms can include right upper quadrant abdominal pain, jaundice, and coagulopathy (bleeding problems), progressing to liver failure and potentially death.

Risk factors that increase the likelihood of severe liver injury include exceeding the maximum daily dose, taking the medication alongside other products containing acetaminophen, or having a history of chronic alcohol misuse or repeated supratherapeutic ingestions.

Required Emergency Action

In case of accidental overdose, get medical help or contact a Poison Control Center right away. Prompt treatment is essential to mitigate the risk of irreversible liver damage.

Therapeutic Uses of Aceper

Aceper is indicated for the management of certain chronic, recurring conditions that affect the nervous system. The medication is designed to help address the frequency and severity of symptom flare-ups associated with these long-term neurological challenges. Aceper provides symptomatic relief by targeting discomfort and by helping to support daily functional capacity in patients with ongoing issues. It is part of a therapeutic approach intended for conditions such as chronic neuropathic discomfort, recurrent neurological dysfunction, and related challenges involving sensory processing. As a component of a long-term treatment strategy, Aceper may support overall wellness and may assist in improving the quality of life by supporting more restful sleep and potentially reducing fatigue associated with the condition.


Quick Fact: Symptom Management for Chronic Conditions

Aceper is formulated to offer symptom management for the persistent and recurring discomfort associated with its approved neurological health conditions. It may assist in maintaining stability in the condition.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Aceper — Official Regulatory Information

The eligibility profile for Aceper (Perindopril) is strictly defined by government regulatory documents, outlining populations that are permitted, restricted, or absolutely prohibited from using the medicine.

Eligibility scope Official Regulatory Status (Strictly Label-Based)
Populations for whom use is allowed (as stated in label): Adult patients (typically 18 years of age) with Hypertension or Stable Coronary Artery Disease.
Populations for whom use is not recommended (if applicable): Pediatric patients (leq 18 years); First trimester of pregnancy; Breastfeeding mothers; Patients with severe renal failure (CrCl <30 mL/min).
Populations for whom use is contraindicated: Patients with a history of angioedema (swelling) from any ACE inhibitor or hereditary/idiopathic angioedema. Women in the second and third trimesters of pregnancy. Concomitant use with sacubitril/valsartan (within 36 hours). Concomitant use with aliskiren in patients with Diabetes Mellitus or renal impairment.
Age-related eligibility rules: Pediatric Use: Safety and efficacy have not been established; Older Adults: Use is allowed but may require lower starting doses.
Condition-specific eligibility rules: Severe Renal Impairment: Use is generally not recommended. Hepatic Impairment: Use requires caution and close monitoring.

Connection to the overall eligibility profile

Regulatory documents strictly define eligibility through absolute contraindications related to angioedema history and late-stage pregnancy, and through conditional restrictions placed on pediatric patients and those with organ-function impairment or specific co-existing therapies. These official classifications explicitly prohibit or limit the drug's use in specific populations.

What should I know about interactions with other medicines?

Aceper Interactions with Other Medicines and Products

This section details officially documented interactions for Aceper, focusing on how co-administration with other medicines, food, or products can alter its effects, as defined by regulatory bodies.


Contraindicated and High-Risk Combinations

Classification Interacting Agents
Do Not Combine Other products containing Paracetamol (Acetaminophen) due to risk of exceeding the maximum safe daily dose.
Avoid for Specific Period Mifepristone; use of the Aceper component must be avoided for 8–12 days following Mifepristone administration.

Clinically Significant Interaction Categories

Interactions primarily fall into domains affecting bleeding risk, renal function, and drug metabolism:

  • Agents Affecting Bleeding Risk: Co-administration with Anticoagulants (e.g., Warfarin) or Corticosteroids enhances the risk of bleeding and gastrointestinal damage, requiring strict monitoring.
  • Effects on Renal Clearance: Certain substances, including Diuretics, Lithium, and Ciclosporin, are officially documented to affect the renal clearance of the Aceper component, potentially increasing drug concentrations or reducing the efficacy of the co-administered agent.
  • Metabolic Interactions: The risk of liver toxicity from the Paracetamol component is officially documented to be significantly increased when co-administered with chronic alcohol or certain enzyme-inducing anticonvulsants (e.g., Phenytoin, Carbamazepine).

Note on the Elderly: Official documentation emphasizes that elderly patients face a higher susceptibility to adverse outcomes, particularly renal impairment and GI bleeding, when Aceper is co-administered with diuretics or ACE inhibitors.

Mechanism of Action

How Aceper Works: Mechanism of Action

Aceper’s pharmacodynamic action operates across two distinct mechanistic domains: enzyme inhibition and connective tissue modulation. The drug acts primarily as an enzyme inhibitor, targeting specific enzymes in the eicosanoid pathway. This mechanism involves blocking the activity of cyclooxygenase-2 (COX-2), which reduces the cellular conversion of arachidonic acid into pro-inflammatory mediators, such as prostaglandins. This cascade results in a physiological decrease in localized inflammatory signaling activity, evidenced by a reduction in processes like vasodilation and localized temperature increase.

Simultaneously, Aceper functions as a biological modulator within connective tissue metabolism. It influences the balance of enzyme activity in these pathways by modulating the action of catabolic enzymes, including matrix metalloproteinases. This action affects the processes that regulate the degradation of structural components, such as cartilage, influencing the overall balance of tissue metabolism in affected areas.

Dosage and Administration Information

The administration of Aceper, whose active ingredient is Perindopril, involves a specific route, dosing schedule, and required adjustments.

Aceper is available as oral tablets in strengths including 2 mg, 4 mg, and 8 mg. The primary instruction is to take the medicine once daily in the morning, preferably before a meal, to ensure optimal absorption.


Official Dosing and Titration

Indication Initial Dose (Adults) Maintenance Dose Maximum Daily Dose
Hypertension 4 mg once daily 4 mg to 8 mg once daily or in two divided doses 16 mg
Stable Coronary Artery Disease 4 mg once daily for 2 weeks 8 mg once daily 8 mg

Treatment initiation and any dose increase require close medical supervision, typically for the first two weeks. The dosage is increased, or titrated, based on the individual response to ensure stable management.

Population-Specific Use

Specific adjustments are utilized for certain populations. Older adults should begin at a lower initial dose, such as 2 mg to 4 mg per day, and the dose should be increased cautiously, with experience limited for doses exceeding 8 mg. For patients with moderate renal impairment (kidney issues), the initial daily dose is 2 mg, and the total daily dose should not exceed 8 mg. If a dose is forgotten, the instruction is to take it as soon as it is remembered, unless it is almost time for the next scheduled dose, in which case the missed dose is skipped. A double dose must not be taken.

Recent Clinical Evidence

Aceper: Overview of Research Evidence

Research exploring Aceper (Perindopril) is grounded in large Randomized Controlled Trials (RCTs) and meta-analyses, examining its effects across several cardiovascular conditions. Findings are generally derived from studies that tracked major cardiovascular events over extended observation periods, often ranging from four to five years.

Essential Hypertension (High Blood Pressure)

Studies examined Blood Pressure (BP) measurements and tracked patterns related to major long-term cardiovascular outcomes like stroke and myocardial infarction in adults with high blood pressure. Research describes changes in systolic and diastolic BP observed during the study period. When comparing Aceper to other treatments, limitations exist due to differences in patient groups and trial design, known as clinical heterogeneity.

Stable Coronary Artery Disease (CAD)

Evidence for patients with stable CAD is largely based on large placebo-controlled trials. These studies examined a Composite Endpoint defined by major adverse events (including cardiovascular death and non-fatal myocardial infarction). The results apply to populations where Aceper was typically used as part of a combination treatment regimen alongside other standard care medications.

Chronic Heart Failure and Stroke Prevention

In the context of chronic heart failure (CHF), studies have examined outcomes related to hospitalization due to heart failure and changes in functional status. For secondary stroke prevention, research examined Aceper, often as a combination therapy with a diuretic, to track the rate of recurrent stroke in adults with a prior event. Certainty remains low for some long-term outcomes in specific groups, such as older adults with heart failure, due to trials being statistically underpowered or having high rates of patient withdrawal.

Frequently Asked Questions (FAQ)

Common questions about Aceper (FAQ)


Q: How quickly does Aceper start working?

A: Aceper is designed as a prodrug, meaning it needs to be processed in the body to become the active therapeutic substance, perindoprilat. Peak blood levels of the active substance are typically reached about 3 to 7 hours after the tablet is taken. The maximal effect on the target enzyme is generally observed within 4 to 6 hours after dosing, according to official documents.


Q: Are headaches a common side effect when starting Aceper?

A: Headaches are documented as a Common side effect in the official safety profile, meaning they affect between 1% and 10% of patients. While regulatory information establishes this frequency, it does not explicitly confirm that headaches will only occur when starting the medication, but they are a commonly reported event.


Q: Does Aceper cause weight gain or weight loss?

A: Changes in body weight are not listed among the frequently reported side effects in the official product information. Regulatory information indicates that rapid weight changes can sometimes be a sign of a serious condition, such as kidney or heart failure.


Q: Is Aceper known to affect sleep patterns?

A: Official product monographs sometimes list sleep disturbances as a potential, though Uncommon, side effect, affecting less than 1% of patients. Significant changes in sleep are among the symptoms noted that a patient should report to their prescribing healthcare provider.


Q: Does Aceper interact with common pain relievers?

A: Yes, regulatory documents describe interactions with certain pain relievers. The combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class including some pain relievers, is generally not recommended, as this combination can increase the risk of worsening kidney function. Interactions are also documented with Paracetamol (Acetaminophen) due to risks associated with the combination product.


Q: What types of food or drinks should be avoided while using Aceper?

A: Official sources advise caution regarding supplements and foods high in potassium, such as salt substitutes. Aceper can cause potassium levels in the blood to rise, and high-potassium foods may increase this risk. Chronic consumption of alcohol is also documented to increase the risk of side effects.


Q: Is it possible to take Aceper with alcohol?

A: Official documentation notes that alcohol can increase the blood pressure-lowering effect of the medicine, which may lead to dizziness or lightheadedness. Official sources recommend that questions about consuming alcohol should be referred to a healthcare provider.


Q: Can Aceper be taken with supplements or vitamins?

A: Official warnings exist for any supplements or vitamins that contain potassium, as taking them with this medicine could lead to dangerously high potassium levels. Any questions about combining this medicine with other supplements should be referred to a healthcare provider.


Q: Does having liver disease affect the use of Aceper?

A: Yes, official labeling states that use requires caution in patients with hepatic impairment (liver disease). Aceper is a prodrug that needs to be converted in the body to become active. Official documentation indicates that the use of this medicine in the presence of hepatic impairment requires caution and careful medical monitoring.


Q: Can Aceper make you feel dizzy or lightheaded?

A: Dizziness is documented as a Common side effect in the official safety profile. The medicine works to lower blood pressure, and symptomatic hypotension (a drop in blood pressure) is listed as a potential reaction that can cause feelings of lightheadedness or fainting, particularly when starting treatment or when the dosage is increased.


Q: Are there skin reactions sometimes seen with Aceper?

A: The most serious, though uncommon, skin-related reaction documented in the label is Angioedema, a severe swelling of the face, tongue, or throat, which requires immediate medical attention. Mild skin rashes are also reported as an Uncommon side effect in official documents.


Q: How long do the effects of Aceper usually last?

A: Aceper is specifically designed for once-daily dosing. Regulatory studies indicate that the drug provides sustained inhibition of the ACE enzyme, meaning substantial therapeutic effects are still present 24 hours after a dose.


Q: Is Aceper considered a high-risk medication?

A: Official regulatory documents do not classify medicines using the term 'high-risk.' Instead, they highlight specific Warnings and Precautions related to serious, though uncommon, reactions. The label emphasizes the importance of avoiding the medicine if a patient has a history of swelling (angioedema) from other medicines in this class.


Q: What are the most commonly reported side effects of Aceper?

A: The most frequent documented side effect is a Cough (non-productive and persistent), classified as Very Common (affecting 10% or more of patients). Other Common side effects include headache, dizziness, tiredness (asthenia), low blood pressure (hypotension), nausea, and diarrhea.


Q: Do the side effects of Aceper usually go away over time?

A: Regulatory-sourced patient information suggests that some common side effects, such as the dry cough, may lessen or go away with continued use. Regulatory guidance suggests that persistent side effects should be discussed with the prescribing healthcare provider.


Q: Is Aceper prescribed for children or teenagers?

A: Official regulatory labeling explicitly states that the safety and effectiveness of Aceper have not been established in pediatric patients (children and teenagers). For this reason, its use is generally not recommended in those under the age of 18.


Q: Is Aceper a controlled substance?

A: Based on official regulatory records, such as those maintained by the DEA in the US, the active ingredient in Aceper (Perindopril) is not scheduled as a controlled substance.


Q: What happens if I forget a dose of Aceper?

A: Regulatory guidance advises taking the missed dose as soon as it is remembered, unless it is nearly time for the next scheduled dose. If it is close to the next dose, the missed dose should be skipped entirely, and the normal schedule resumed. Regulatory guidance specifically states that a double dose must not be taken to make up for a forgotten one.


Q: Is the generic version of Aceper as effective as the brand name?

A: Generic versions of the medicine are required by regulatory bodies (such as the FDA) to be therapeutically equivalent to the brand-name product. This means the generic must contain the same active ingredient and work in the same way, achieving the same quality and strength.


Q: Are there long-term health risks associated with Aceper use?

A: Clinical studies have tracked long-term cardiovascular outcomes over several years to support its approved use in chronic conditions. However, the regulatory label highlights that long-term use requires monitoring of serum potassium levels and renal function due to the associated risks in these areas.


Q: Is it normal to feel tired after taking Aceper?

A: The feeling of tiredness or general body weakness, referred to as Asthenia in medical documents, is classified as a Common side effect in the regulatory safety profile. This means it affects between 1% and 10% of patients.


Q: Is Aceper associated with any specific mood changes?

A: Some official product information lists general Mood disturbances or Depression as a potential side effect. These are usually classified in the Uncommon category, meaning they affect less than 1% of patients.

How should Aceper be stored and disposed of?

How to Store and Dispose of Aceper?

Official labeling requires Aceper tablets to be stored under specific environmental constraints to maintain product stability and quality. The product must be stored at controlled room temperature, specifically below 30°C (86 F), and must be protected from light and moisture. It is required that the container remains tightly closed and the medicine is kept from freezing.

Child Safety and Disposal

Aceper must be stored out of the sight and reach of children at all times. Disposal must follow strict environmental regulations: the product must not be thrown away via wastewater or household waste. Expired or unused medication should be discarded according to local regulations or returned to a pharmacy or approved waste disposal program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aceper found in:

A-Z Index: